Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-123,577
Closed -$12.7M 963
2026
Q1
$12.7M Sell
123,577
-41,600
-25% -$4.24M 0.02% 543
2025
Q4
$16.6M Buy
165,177
+88,489
+115% +$8.73M 0.03% 489
2025
Q3
$6.63M Hold
76,688
0.01% 672
2025
Q2
$5.85M Hold
76,688
0.01% 683
2025
Q1
$5.44M Buy
76,688
+19,987
+35% +$1.56M 0.01% 672
2024
Q4
$4.44M Buy
56,701
+9,241
+19% +$863K 0.01% 670
2024
Q3
$4.86M Sell
47,460
-40,233
-46% -$3.34M 0.01% 651
2024
Q2
$6.65M Buy
+87,693
New +$6.24M 0.01% 583

Other funds holding NUVL

Aberdeen Group's NUVL Position: Q2 2026 in Review

Aberdeen Group sold out of Nuvalent (NUVL) in Q2 2026, closing a stake of 123,577 shares — an estimated $12.7M sold.

Aberdeen Group first reported a position in NUVL in Q2 2024 and held it in 8 quarters. The position peaked at $16.6M in Q4 2025. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • Aberdeen Group reported no remaining Nuvalent position as of Q2 2026 after selling out during the quarter.
  • Aberdeen Group sold 123,577 Nuvalent shares in Q2 2026, an estimated $12.7M.
  • Aberdeen Group first reported a position in Nuvalent in Q2 2024 and held it in 8 quarters.
  • Aberdeen Group's Nuvalent position peaked at $16.6M in Q4 2025.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.